Relative deficiency in circulating levels of insulin-like growth factor I (IGF-I) during long-term treatment with a GnRH agonist.
Fiore
C E
CE
Second Department of Internal Medicine, University of Catania, Italy.
Dieli
M
M
Caschetto
S
S
Cirino
A
A
Cottini
E
E
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000172:deficiency*; D007889:Leiomyoma / Q000188:drug therapy; D008875:Middle Aged; D017329:Triptorelin Pamoate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000188:drug therapy
D018931:Antineoplastic Agents, Hormonal; D018972:Insulin-Like Growth Factor Binding Protein 3; D017329:Triptorelin Pamoate; D004958:Estradiol; D007334:Insulin-Like Growth Factor I